<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Taltirelin</id>
	<title>Taltirelin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Taltirelin"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Taltirelin&amp;action=history"/>
	<updated>2026-04-27T03:43:21Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Taltirelin&amp;diff=5637827&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Taltirelin&amp;diff=5637827&amp;oldid=prev"/>
		<updated>2024-04-20T13:57:09Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Talitirelin.png|Talitirelin|thumb]] &amp;#039;&amp;#039;&amp;#039;Taltirelin&amp;#039;&amp;#039;&amp;#039; is a synthetic [[analogue]] of the hormone [[thyrotropin-releasing hormone]] (TRH). It is primarily used in the treatment of [[spinocerebellar ataxia]], a condition characterized by progressive problems with movement. Taltirelin acts by mimicking the action of TRH, which is a tripeptide hormone produced in the [[hypothalamus]]. TRH plays a crucial role in the regulation of the [[thyroid gland]], stimulating the release of [[thyroid-stimulating hormone]] (TSH), which in turn stimulates the production of thyroid hormones. However, the effects of taltirelin extend beyond the stimulation of thyroid hormone production, exhibiting neuroprotective and neurotrophic effects that are beneficial in the management of neurodegenerative conditions like spinocerebellar ataxia.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
Taltirelin increases the synthesis and release of [[acetylcholine]] in the brain, which is believed to contribute to its therapeutic effects in treating spinocerebellar ataxia. The drug has been shown to improve motor function in patients with this condition, likely due to its ability to enhance cholinergic neurotransmission and protect neuronal cells from degeneration.&lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
Taltirelin is approved in Japan for the treatment of spinocerebellar ataxia. Its use is specifically indicated to improve the symptoms of this disease, such as difficulties with gait and balance. The medication is administered orally, and its dosage may vary depending on the severity of the condition and the response of the patient.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
The side effects of taltirelin are generally mild and may include headache, nausea, and dizziness. These side effects are typically transient and resolve with continued treatment. However, as with any medication, some patients may experience more severe adverse effects, and it is important for individuals taking taltirelin to be monitored by a healthcare provider.&lt;br /&gt;
&lt;br /&gt;
==Research==&lt;br /&gt;
Research on taltirelin has explored its potential benefits beyond the treatment of spinocerebellar ataxia. Studies have investigated its effects on cognitive function, depression, and other neurological conditions, suggesting that taltirelin may have broader applications in the field of neurology. However, further research is needed to fully understand its mechanisms of action and potential therapeutic uses.&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Neurology]]&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>